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Introduction: The opioid use crisis has left nearly 1 million people in need of treatment. States 
have focused primarily on policies aimed at decreasing the prevalence of opioid use disorder. 
However, opioid treatment programs (OTPs), an evidence-based modality which can prevent and 
decrease opioid-related mortality and morbidity, remain highly complex with variation in 
treatment by state. A focus on evidence-based state-level regulation of OTPs may help improve 
the unmet need for treatment. This study characterized the variability in state laws that regulate 
OTPs and examines how this variability is associated with state characteristics. These data 
provides an opportunity for policymakers to consider regulations that increase access to care and 
retention in OTPs, which could improve population health. 
Materials and Methods: Utilizing legal mapping techniques, we identified all regulations 
governing OTPs in effect on January 1, 2017 and determined whether the most common 
regulations were consistent with best practices. We then examined how the number and type of 
regulations were associated with state characteristics. All legal mapping research was conducted 
between November 2017 and March 2019.   
Results: We identified 89 different regulations, the most common of which exists in fewer than 
half of all states; and most exist in less than 25% of states. Eighteen of the 30 most common 
regulations were inconsistent with best practice recommendations. Overall, variability in the 
number and type of OTP regulations was related to geographic location as opposed to state size 
or political leanings. 
Conclusions: Wide-ranging variability in the regulations of OTPs exists across the U.S. The 
majority of state OTP regulations are not congruent with best practices.  
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The U.S. is currently experiencing a crisis with nearly 2.1 million people suffering from 
opioid use disorder (OUD) of whom over 300,000 receive care from 1,500 opioid treatment 
programs (OTPs) (Wickersham & Basey, 2016; Substance Abuse and Mental Health Services 
Administration [SAMHSA], 2015; SAMHSA, 2016). However, when comparing treatment 
capacity of medications for opioid use disorder (MOUD) and patient need, over 1 million people 
remain in need of services (Jones, Campopiano, Baldwin, & McCance-Katz, 2015). Recently, 
states have attempted to address the opioid epidemic by focusing on policies aimed at decreasing 
the prevalence of OUD such as a reduction in opioid prescribing and decreased production of 
opioids (SAMHSA, 2015b; Kertesz, 2017). Previous attempts to address the opioid epidemic 
through policy are not believed to be sufficient in order to improve the situation (Kertesz, 2017). 
A focus on evidence-based state regulation of OTPs which improves the wellbeing of individuals 
with OUD may be a solution to decrease illicit opioid use and may help meet the needs of those 
experiencing use disorder.  
Facilities that use medications to treat individuals with OUD have been subject to varying 
degrees of regulation at the federal level since the inception of “opioid maintenance programs” 
and “dispensaries” in the early 1900’s (Peters, 1983). The 1914 Harrison Narcotic Act restricted 
the use of opiates, subsequently prohibiting medication-assisted treatment (MAT) however by 
the early 1970s, regulatory reform and political pressures eased lifting the prohibition of MAT 
and modern-day OTPs emerged("The Comprehensive Drug Abuse Prevention and Control Act ", 





and Drug Administration (FDA), enforced by the Drug Enforcement Administration (DEA), 
while standards and certification for treatment are created by the Substance Abuse and Mental 
Health Services Administration (SAMHSA) (Joseph,  Stancliff, & Langrod, 2000) & Center for 
Substance Abuse Treatment [CSAT], 2005). In addition, various state and local regulations 
govern facility operations, clinical care, and staffing in OTPs (Joseph et al., 2000; "Title 42 of 
the Code of Federal Regulations Part 8," 2001). Due to the multi-layered oversight causing 
complexity, OTP regulations has been referred to as a “regulatory fog” (Wickersham & Basey, 
2016).  
OTPs provide comprehensive care for individuals experiencing OUD including 
counseling, medical assessments, and MAT (CSAT, 2005).  OTP providers primarily utilize 
methadone, a synthetic opioid15 to eliminate or decrease the use of opioids (Goldstein & Herrera, 
1995; Mattick, Breen, Kimber, & Davoli, 2009), reduce associated mortality (Gibson et al., 
2008; Grönbladh, Öhlund, & Gunne, 1990; Langendam, Van Brussel, Coutinho, & Van 
Ameijden, 2001), criminality (Dole, Nyswander, & Warner, 1968; Farrell et al., 1994), and allow 
patients to improve their physical, mental and social wellbeing (Joseph et al., 2000; Sun et al., 
2015). Previous research has demonstrated, a relationship between state policy requirements and 
OTP activities (Chriqui, Terry-McElrath, McBride, & Eidson, 2008; Chriqui, Terry-McElrath, 
McBride, Eidson, & VanderWaal, 2007). Researchers believe state policy environments are 
important determinants in the effectiveness of services offered to those in need (Miller & 
Moulton, 2013), and this may in turn explain current variation in treatment and health outcomes 
across states. To date, however, research on the association of state-level OTP regulation and 
health outcomes are limited due to the empirical challenges and impracticality of measuring the 






The purpose of this paper is to characterize the variability in state laws that regulate 
OTPs and examine how this variability is associated with state characteristics such as geographic 
region, population size, and the political leanings of states’ population. As political factors have 
played a role in the regulation of OTPs (Berridge, 2009; Kuehn, 2005), we are interested in 
examining if political leanings are related to current policies. We are interested in identifying the 
most common regulations and characterizing the extent to which these regulations are evidence-
based and consistent with recommendations by SAMHSA. Having an accurate representation of 
variability in these laws will allow future research to better examine the impact of these 
regulations on opioid-related health outcomes. Moreover, having the current analysis of the 
regulations will be useful to state policymakers, OTP administrators, and others who need to 
better understand state regulations, and might be considering policy options. 
2. Materials and Methods 
This study utilizes standard public health law research and mapping methods (Anderson, 
Tremper, Thomas, & Wagenaar, 2012; Burris et al., 2010) to systematically code each OTP 
regulation in the 50 states and the District of Columbia (D.C.), hereinafter referred to as “states” 
or  “state-level”, in effect on January 1, 2017.  All legal mapping research was conducted 
between November 2017 and March 2019. Laws for inclusion were identified using keyword 
searches (e.g. opioid treatment programs, narcotic treatment, methadone) on Westlaw, Justia, and 
state legislative websites.  Additionally, publicly available lists of OTP regulations published by 
the Prescription Drug Abuse Policy System (Prescription Drug Abuse Policy System [PDAPS], 
2018), were used to assure all relevant laws were identified in our keyword searches. A single 





states to assure consistency in coding.  No cases were identified where separate researchers 
coded laws differently.  The institutional review board at our university deemed this study as not 
human subject’s research. 
The main dependent variables were a series of indicators measuring the presence or 
absence of different elements of OTP regulation that occur in any state.  OTP regulations were 
defined as those that govern organizations, consistent with SAMHSA’s definition of OTPs 
(SAMHSA, 2015b; "Title 42 of the Code of Federal Regulations Part 8," 2001), administering 
and dispensing medication assisted treatment for the treatment of OUD (SAMHSA, 2015b). 
Therefore, per the federal definition, facilities, such as physician office-based practices, that only 
prescribe buprenorphine and substance use facilities who are not certified by SAMHSA as an 
OTP are excluded from the definition. 
Individual state laws were analyzed and coded into a database such that the entire 
landscape of OTP regulations were captured.  Per standard protocols (Burris, 2018; Wagenaar & 
Burris, 2014), information was extracted from an initial group of ten states so emerging themes 
could be established—and then these states were recoded for consistency.  This process was 
repeated with 10 additional states at a time until no new themes or elements were identified.  In 
cases where no applicable regulations were found, state OTP governing bodies were contacted to 
obtain further information or to validate the absence of regulations.  Stateregulations that were 
identical to federal laws were coded as not having any unique regulations. 
Each binary variable measuring the presence of a given regulation was categorized as 
pertaining to one of the following six categories: regulations pertaining to medical service 
delivery (e.g., required testing for tuberculosis), facility operating requirements (e.g., regulations 





improvement plans), staffing requirements (e.g., required use of certain advanced practice 
professions), social services related regulations (e.g., requirements for patient discharge or 
aftercare plan), and physical facility management provisions (e.g., requirements of facility 
cleanliness). These categories emerged during the open coding process. Two members of the 
research team met regularly to build consensus around the emerging categories. Lastly, for the 
five most common regulations in each of the six categories (for a total of 30), we classified each 
item as a ‘best practice’ (or otherwise) based upon SAMHSA’s list of best practices (SAMHSA, 
2015, CSAT, 2005, & "Title 42 of the Code of Federal Regulations Part 8," 2001) and/or the 
presence of published literature supporting these practices.   
To examine how OTP regulations are associated with state characteristics, we merged in 
variables including 2017 state population estimates, regions as defined by the US Census 
Bureau, and the proportion of each state that voted for the Democratic and Republican 
candidates, respectively, in the 2016 presidential election.  States were categorized according to 
natural cut off-points into small (less than 2 million people), medium, and large (more than 9 
million people) groups based on population size. The political leanings of states were categorized 
by the proportion of the population that voted for the Republican or Democratic candidate in the 
2016 presidential election which was obtained from the Federal Election Commission (Federal 
Elections Commission, 2016).  Specifically, we created three categories as follows: (1) states 
where 55% or greater voted for the Republican candidate, (2) states where 55% or greater voted 
for the Democratic candidate, and (3) states where neither the Democratic candidate nor the 
Republican candidate received at least 55% of the populous vote. 





To analyze our data, we began by examining the frequency of each type of regulation 
across the states and D.C. We then created summated scales that were calculated as the total 
number of individual regulations within each category of OTP regulations.  For example, given 
we identified 26 individual types of regulations in the Medical Services Delivery category, our 
summated scale for this category could range from 0 to 26 representing the number of unique 
regulations a given state possessed.  We calculated a summated scale for each of the 6 categories 
and one overall scale that represented a count of all OTP regulations a given state possessed.  
The summated scales ultimately allowed us to quantify the number of regulations that govern 
OTPs in a given state within each category and overall.  
Next, we examined the relationship between the summated scales and the above state 
characteristics using analyses of variance (ANOVA).  All statistical analyses were conducted 
using SPSS version 25 and statistical significance was assessed at the P< 0.05 level. 
3. Results 
As of January 1st, 2017, 47 states had specific regulations governing the operation of 
OTPs (KS, MT, and WY did not). Two states (ID, NE) regulations were redundant with federal 
guidelines. In total, 89 individual regulations were identified of which 26 were categorized as 
pertaining to medical services delivery, 6 pertained to facility operating requirements, 15 
pertained to administrative requirements, 19 pertained to staffing requirements, 8 to social 
services related regulations, and 15 to physical facility management provisions.   
The frequency in which each of the individual regulations were found appears in Table 1. 
Briefly, 42 (82.4%) of states had at least one OTP regulation governing medical services delivery 
which was the most common category of regulation.  The next most common regulations were 





(78.4%), facility operating requirements 37 (72.5%), social services 28 (54.9%), and physical 
facility management requirements 28 (54.9%).  The map in figure 1 provides a visual display 
that identifies the frequency of the 89 regulations in each state.   
Table 2 presents information on whether each of the top 5 most frequent regulations in 
each category was recommended by SAMHSA and/or deemed a best practice. The map in figure 
2 provides a visual display of the frequency of common regulations which are best practices in 
each state. Among the Medical Services Delivery Requirements, only 1 of the 5 most common 
regulations, specifically, the requirement OTPs ensure humane dosage withdrawal schedules, 
was considered a best practice by SAMHSA. Among the Administrative Requirements, 3 out of 
the 5 most common regulations were considered a best practice including requiring a facility 
quality improvement plan, requiring OTPs to have a patient grievance policy, and requiring 
OTPs to have a community relations committee.  Among the Staffing Requirements, 2 of the 5 
most common regulations were considered best practices including the employment of advanced 
practice professionals, and utilization of a clinical supervisor.  Among the Facility Operating 
Requirements, only 1 of the 5 most common regulations, specifically, restrictions on the hours of 
operation were consistent with best practices.  
Among the Social Services Related regulations, 4 of the 5 most common laws were 
consistent with best practices including requiring patient discharge or aftercare plans, 
integration of patient’s family into treatment and goals, requirements to provide crisis 
stabilization services, and requirement the provision of parenting skills in patient education 
activities. Lastly, among the Physical Facility Management requirements, 1 out of the 5 most 
common elements were consistent with best practices; specifically, OTP requirements on facility 





facility signage was present in the regulations of 10 states with much variability in language. 
Specifically, in addition to signage consistent with best practice recommendations, D.C. also 
requires “metric-apothecaries weight and conversion measure charts” to be posted within the 
facility (“Title 22-A 62 37 DCR 012056”, 2015) which are not included in the SAMHSA 
guidelines. 
Table 3 presents information on the mean number of OTP regulations, by category and 
overall, and how these summated scales are related to state characteristics.  When examining 
U.S. Census regions, several differences were noted.  First, states in the West region (average of 
7.2 regulations) had significantly fewer OTP regulations in total than states in the Northeast 
(average of 18.8), Midwest (average of 11.3), or South (21.8) p<0.001.  Notably, states in the 
South had significantly more regulations in the categories of Administrative Requirements, 
Staffing Requirements, Facility Operating Requirements, and Social Services categories (all 
P’s<0.05); while states in the West had significantly fewer regulations in these categories.  
Lastly, no differences in the mean number of OTP regulations was observed by population size 
or the political leanings of states.   
4. Discussion  
Our study is the first to quantify the entire landscape of state OTP regulations that have 
previously been described as a “regulatory fog” (Wickersham & Basey, 2016). Supplementing 
the extensive federal regulations, our study identified 89 different individual regulations that 
currently exist among states.  Importantly, we observed much variability in both the types and 
the frequency of these regulations.  For example, even the most common individual regulations 
(e.g., required testing for tuberculosis, required patient discharge plans) only exist in fewer than 





considered a laboratory to examine the effects of different policies which allows successful laws 
to be replicated by other willing states (Savino, 2009). However, in the case of OTPs, we observe 
much variation in enacted regulations without the historical ability to determine which laws have 
improved population health. 
We found the majority (18 out of 30) of the most common regulations overall, and 
specifically the most common regulations in the Medical Services Delivery, Staffing, Facility 
Operations, and Physical Facility Management categories, were not considered best practices by 
SAMHSA and the literature. This raises the question regarding whether the extent of 
unsupported state policies might make it more challenging to address the current OUD epidemic 
and the almost 1 million individuals currently in need of services (Jones et al., 2015). For 
example, within the Medical Service Delivery category, the most common regulation was 
required testing for tuberculosis; and this was not classified as a best practice. Notably, 
individuals with OUD are not typically considered high risk populations who require regular 
screening (Centers for Disease Control and Prevention [CDC], 1990).  Furthermore, the Centers 
for Disease Control and Prevention (CDC) recommends that providers use tuberculin skin-
testing only if the evaluation and a course of prescribed therapy can be initiated and completed, 
which is usually not within the scope of practice for OTPs (CDC, 1990).  Thus, the increased 
cost of any unnecessary screenings adds to the overall costs of treatment which may contribute to 
decreased access and resources. Tuberculosis screenings contrast with screenings for hepatitis C 
and HIV (which are largely not required by most states) and are considered a best practice 
because those seeking care in OTPS are at elevated risk (Frimpong, 2013; Frimpong, D’Aunno, 





Similarly, SAMHSA explicitly discouraged the use of certain regulations that restrict 
unsupervised dosing of methadone by patients outside of the clinic.  Nevertheless, many states 
have such regulations in effect.  SAMHSA acknowledges that being able to utilize take-home 
medication is of critical importance for patients and impacts their ability and desire to enter and 
remain in treatment; and federal regulations permit one take-home dose per week in the first 90 
days (CSAT, 2005). In our study, we found 12 states (23.5%) that do not allow any take-home 
medications during the first 30 days and 7 additional states (13.7%) that do not allow any during 
the first 90 days.  Medication diversion is often cited as justification for these restrictions, 
however it has been noted that methadone is not often diverted, especially to individuals for 
recreational use; and when it is diverted it is often to individuals with OUD who lack access to 
treatment (National Institutes of Health [NIH], 2007). 
The most common regulations in the Social Services category (4 out of 5) and the 
Administrative requirements category (3 out of 5) were supported by evidence and thus endorsed 
by SAMHSA.  As such, there appears to be some variability, by regulation-category, in the 
implementation of best practice regulations.  More research is needed to determine if best 
practice policies result in improved health outcomes; and whether regulations without supporting 
evidence result in poorer health outcomes across states. 
Importantly, we found variability in both the number and type of OTP regulations was 
related to geographic location as opposed to state size or political leanings.  The states in the 
West had the fewest number of OTP regulations overall, and by each of the categories observed.  
On the other hand, the Southern region of the US consistently had the highest number of 
regulations in each of the categories and overall.  This might be related to documented higher 





Yingling, & Shannon, 2018). Further, given a high proportion of Black residents in the South, the 
observed higher frequency of certain regulations, particularly those not considered best practices, 
could contribute to documented racial disparities in access to OUD treatment described in the 
South (NIH, 2007; Abraham et al., 2018; Napoli et al., 2017). Examining these relationships are 
important for future research. 
Previous researchers have suggested that political leaning may play a role in OTP 
policies (Berridge, 2009; Kuehn, 2005). Our study failed to find evidence for this assertion. 
Generally, we found that the overall number of regulations did not differ with respect to states 
considered Republican, Democratic, or swing based on voting records from the most recent 
presidential election. However, given the historical context in which OTP have been regulated, 
more research is warranted to determine the extent to which public opinion, race, or 
socioeconomic status explain the variation in state regulations given that current political leaning 
do not appear to do so. The opioid crisis represents a bipartisan opportunity for policymakers to 
consider regulations that increase access to proven OTP treatment which may then result in 
overall improvement to population health. 
Our study findings must be understood in the context of some limitations.  First, we 
examined and coded OTP regulations as they are written and did not account for varying levels 
of enforcement and interpretation.  We recognize that actual practice may vary from the 
regulations as they are written. Further, our study focused on state regulation; and we recognize 
that county-level regulations and state-level professional practice boards could exist that 
influence OTPs. We did not examine regulations which govern all MOUD delivered outside of 
the OTP setting. Moreover, to measure the complexity of OTP regulations we utilized a simple 





within different categories.  We recognize that future research could improve on this approach by 
utilizing methods that differentially weigh regulations based on the evidence that underpins 
them.  Finally, we determined whether a type of regulation was considered a best practice based 
on SAMHSA guidelines that are largely based on expert opinion rather than empirical evidence 
in many cases.  More empirical data on how regulations and best-practice guidelines affect 
health outcomes is warranted.  
As the majority of the most common regulations were not considered best practices, we 
must consider the possibility that state policies may be creating barriers to access and retention in 
treatment. Our study lays the foundation for future work to allow for more rigorous evaluations 
of how OTP regulations affects the establishment, functioning, and performance of OTPs.  In 
addition, our study enables future research to examine the impact of OTP regulations on 
overdose deaths, the number of patients served, and other population health outcomes.  In the 
meantime, our data can serve as a starting point for discussion among policymakers and experts 
who can evaluate their own state’s regulations and determine which individual regulations might 
be helpful or harmful in addressing the opioid crisis.   
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regulation States with this regulation 
Medical Services Delivery Requirements Category N=42 82.4%  
Required testing for tuberculosis 
24 47.2% 
AK, AL, AR, CA, CO, GA, IA, IL, IN, ME, 
MI, MO, MS, NJ, NM, NY, OH, OK, OR, SC, 
TX, WA, WI, WV 
Required reporting of patient deaths 
18 35.3% 
AK, CA, CT, DE, GA, IN, KY, LA, MA, ME, 
MI, NY, OK, PA, SC, TX, WA, WI 
Regulations to ensure humane dosage withdrawal schedule 
16 31.4% 
AL, DE, FL, LA, MA, MD, ME, MO, MS, 
NH, NJ, OR, RI, SC, TN, VT 
Limits on unsupervised dosing (more restrictive than Federal) 
15 29.4% 
AL, CA, FL, GA, HI, IN, KY, LA, MA, ME, 
MI, NH, OH, PA, WI 
Required testing for syphilis 
15 29.4% 
AR, CA, CO, IA, IN, ME, MI, NJ, NM, OH, 
OR, RI, SC, TX, WV 
Required lockable container for take-homes (unsupervised dosing) 
14 27.5% 
AK, AL, CO, FL, GA, IN, MA, MD, MO, 
MS, OK, TX, WI, WV 
No take-homes in the first 30 days of treatment 
12 23.5% 
AL, CA, CO, FL, KY, LA, MA, ME, MS, 
NH, PA, WV 
Required complete blood count testing 
11 21.6% 
AR, CO, GA, IN, MA, MI, NJ, NY, RI, SC, 
TX 
Required use of objective measure to test intoxication (e.g. breathalyzer) 9 17.6% AL, AR, DC, KY, MS, NC, NJ, WI, WV 
Mandatory review of patients prescription drug monitoring records 9 17.6% CO, MA, MN, MS, ND, NY, RI, TN, WV 
Restrictions on the use of dose level as a form of punishment  8 15.7% GA, KY, MS, ND, RI, SC, WI, WV 
No unsupervised dosing in the first 90 days of treatment 7 13.7% AL, CA, CO, KY, ME, MS, NH 
Split dosing explicitly allowed without state approval 7 13.7% AL, CA, CO, ME, MS, OK, WV 
Restriction or discouragement of high doses 6 11.8% AR, GA, IA, MS, NC, WV 
Required testing for sickle cell disease  6 11.8% AR, IA, MI, MO, SC, WV 
Required testing of liver function 5 9.8% CO, MA, ME, RI, TX 
Use of tablets or diskettes permitted 5 9.8% ME, NY, OK, OR, SC 
Required testing observed collection of all patient urinalysis 4 7.8% AK, IN, OR, WV 
Restrictions on the use of blind dosing 4 7.8% AK, CO, KY, MA 
Prohibited unsupervised dosing for patients receiving a high dose  4 7.8% AR, CA, IA, MS 
Required testing for hepatitis C 4 7.8% MS, NY, OK, WV 
Regulations on the use of telehealth 3 5.9% AZ, NY, OK 





Requirement to have naloxone and ability to provide overdose management onsite 2 3.9% GA, NY 
Required testing for hepatitis B 2 3.9% MI, MS 
Discourage or prohibit detoxification during pregnancy 2 3.9% CO, NJ 
Administrative Requirements Category N=41 80.4%  
Required facility quality improvement plans 
21 41.2% 
AZ CT, DC, DE, GA, IA, IL, IN, KY, LA, 
MD, ME, MN, MO, NM, NY, OH, OK, OR, 
TN, WV 
Mandatory use of patient central registry 
20 39.2% 
AL, CA, CO, FL, GA, IA, IN, LA, ME, MN, 
MS, NC, NM, NY, OK, RI, TN, TX, VT, WI 
Required patient grievance policy 
19 37.3% 
DE, GA, IN, KY, LA, MA, MD, ME, MO, 
NH, NM, OK, OR, PA, RI, TN, TX, VA, WV 
Mandatory community relations liaison/committee 
18 35.3% 
AR, DE, GA, IN, LA, MA, ME, MN, MO, 
ND, NH, NM, NY, OK, PA, SC, VA, WA 
Mandatory policies on the use of students and/or interns 
11 21.6% 
AZ, DE, KY, LA, MD, ME, NY, OK, OR, 
SD, TX 
Mandatory inclusion of patient photo’s in medical record 7 13.7% AL, CA, MA, MS, PA, RI, WA 
Prohibited policies on kickbacks to patient for new patient referrals  6 11.8% AR, GA, KY, MS, ND, NY 
Restrictions on the use of advertising  6 11.8% AR, DC, IA, LA, MA, TX 
Mandatory patient OTP ID Card 4 7.8% AK, CA, DE, NY 
Restrictions on the maximum fee per patient 2 3.9% IN, TX 
Required periodic update of patient photo in medical chart 2 3.9% PA, WA 
State set maximum patient capacity 2 3.9% CA, ME 
Mandatory algorithm for patient ID # 1 2.0% TX 
Required affirmative action policy 1 2.0% ME 
Prohibited purses or backpacks in facility 1 2.0% MS 
Staffing Requirements Category N=40 78.4%  
Regulations on the employment of advanced practice professionals (e.g. nurse 
practitioners or physician assistants) 19 37.3% 
AL, CA, CO, CT, DC, DE, FL, GA, IN, LA, 
MA, ME, MI, NH, OK, OR, PA, TN, WV 
Required minimum physician or medical director qualifications/certifications 
18 35.3% 
AL, DE, FL, GA, IN, KY, MA, MD, ME, MS, 
NJ, NY, OR, PA, TN, TX, VA, WV 
Required counselor to patient ratio’s 
17 33.3% 
AL, AR, GA, IN, KY, LA, MD, ME, MS, 
NY, PA, SC, TX, UT, WI, WV 
Required employment of a clinical supervisor 
12 23.5% 
AL, CT, IN, KY, LA, MA, ME, NY, OR, TN, 
UT, WA 
Required employment of at least 1 CPR certified employee 
11 21.6% 
AZ, DE, GA, KY, MA, ME, ND, SD, TN, 
VA, WA 
Required employment of a pharmacist 9 17.6% AL, CT, FL, GA, IA, LA, ME, MS, VA 
Required minimum of clinical supervisor qualifications 9 17.6% DE, GA, IN, KY, ME, OK, OR, WA, WV 





Required employment of a registered nurse  8 15.7% IL, LA, MA, MS, NJ, NY, RI, WI 
Required staff tuberculosis testing 7 13.7% DC, IA, IL, MA, MD, TN, WA 
Employment restrictions of administrators with history of criminal or unethical 
behavior  6 11.8% KY, LA, ND, NM, TX, WA 
Requirement of background checks of all employees/ inability to hire employees 
with criminal history 6 11.8% DC, GA, IA, IL, IN, LA,  
Permitted exceptions to minimum qualification of physicians (i.e. interim 
physician) 6 11.8% MD, NJ, NY, PA, VA, WV 
Required nurse to patient ratio 6 11.8% IN, MI, MS, NY, PA, TX 
Required physician to patient ratio 6 11.8% AR, IN, KY, NY, TN, TX 
Requirements related to the employment of peer professionals 6 11.8% DE, IA, LA, NY, OK, VA 
Prohibited from employing patients 3 5.9% FL, OH, OR 
Restrictions on medical director span of control 2 3.9% GA, TN 
Required employment of a health coordinator required 1 2.0% NY 
Facility Operating Requirements Category  N=37 72.5%  
Restrictions on the location of the facility 
22 43.1% 
AL, CT, DC, DE, GA, IA, IL, IN, KY, LA, 
ME, MO, ND, NH, NJ, NV, TN, TX, UT, 
VA, WI, WV                                                                                                                                                                                                                        
Restrictions on the hours of operation  
15 29.4% 
AL, AR, DE, FL, GA, MA, MD, MO, MS, 
NC, NH, NY, OK, VA, WI 
Prohibition of patient loitering  
12 23.5% 
AR, GA, IN, MO, MS, NH, NY, OK, SC, TN, 
VT, WI 
Required to be open 7 days per week 
11 21.6% 
AL, FL, IN, KY, ME, MS, NH, PA, RI, VA, 
WV 
Required certificate of need for new facilities 10 19.6% DE, FL, IN, KY, LA, MO, ND, NM, OK, WA 
Required to be open on holidays 5 9.8% AL, FL, ME, MI, MO 
Social Services Requirements Category N=28 54.9%  
Required patient discharge/aftercare plan 23 45.1% AZ, DC, DE, GA, IN, KY, LA, MA, ME, MI, 
MS, ND, NY, OK, OR, PA, RI, SC, SD, TN, 
VA, WI, WV 
Mandatory inclusion and integration of patient’s family into treatment and goals 16 31.4% AL, AR, DC, DE, IN, LA, ME, MS, NY, OK, 
RI, SC, VA, WA, WI, WV 
Required crisis stabilization services 11 21.6% DC, DE, LA, MA, ME, NY, OK, OR, SD, 
VA, WI 
Required parenting skills patient education 10 19.6% AL, AR, DE, KY, MA, MS, OR, SC, WA, 
WV 
Required life/social skills patient education 10 19.6% AR, DE, KY, LA, MA, ME, MO, OK, OR, 
WV 
Required Anger/stress management patient education 5 9.8% AR, MA, ME, MS, WV 





Required to provide voter registration onsite 1 2.0% OR 
Physical Facility Management Requirements Category  N=28 54.9%  
Requirements on facility cleanliness 18 35.3% CT. DC, DE, IA, KY, LA, MA, ME, MS, ND, 
NM, NY, OH, OK, TX, UT, WI, WV 
Restrictions on Restrooms/Lavatory (e.g. #  of restrooms) 14 27.5% CT, DC, DE, GA, IN, KY, MA, ME, MS, OK, 
PA, UT, WI, WV 
Guidelines on facility ventilation/lighting 12 23.5% CT, DC, IA, IL, IN, KY, LA, MA, ME, OH, 
OR, WI 
Requirements on facility signage (e.g. no smoking signs or posted hours of 
operation) 
10 19.6% AZ, DC, DE, FL, GA, IL, ME, NM, OK, WV 
Guidelines on waiting room layout or location 10 19.6% DE, IN, KY, MA, OH, OK, SC, TX, WI, WV 
Other facility interior requirements 9 17.6% CT, DC, IA, IN, KY, LA, OH, OR, WI 
Required provision of patient privacy while dosing 8 15.7% DE, GA, IN, KY, MI, OH, PA, WI 
Guidelines on the handling hazardous waste 6 11.8% CT, DC, IA, LA, MS, OK 
Mandatory smoke free facilities and grounds 6 11.8% DC, DE, IA, LA, MA, ME 
Other facility exterior requirements 5 9.8% CT, DC, LA, ME, UT 
Guidelines on facility water and sewage 5 9.8% CT, DC, KY, MA, OK 
Guidelines on facility parking 3 5.9% KY, VA, WV 
Required pest control provisions 3 5.9% DC, LA, OK 
Regulations on the use of carpet/rugs 1 2.0% DC 
Required use of interior/exterior video surveillance 1 2.0% MS 
 





Table 2. Degree to which the most common state-level opioid treatment programs (OTP) regulations are considered best practices by SAMHSA or published studies 
  
Category of OTP Regulation 
Best 
Practice? Comments 
Medical Services Delivery Requirements 
Required testing for tuberculosis No OTPs should provide patients with counseling on HIV and other prevalent infectious diseases, such as 
tuberculosis but does not require or suggest testing (Substance Abuse and Mental Health Services 
Administration [SAMHSA], 2015). The CDC recommends that providers use tuberculin skin-testing 
only if the evaluation and a course of prescribed therapy can be initiated and completed, which is 
usually not within the scope of practice for OTPs (“Title 22-A 62 37 DCR 012056”, 2015). Thus, the 
increased cost of any unnecessary screenings adds to the overall costs of treatment which may 
contribute to decreased access and resources. 
Regulations to ensure humane dosage 
withdrawal schedule 
Yes The underlying goal is for involuntary medically supervised withdrawal to reflect a humane partnership 
between the patient and the treatment program (SAMHSA, 2015). 
Limits on unsupervised dosing (e.g., more 
restrictive than Federal) 
No SAMHSA acknowledges that take-home medication are a valuable therapeutic tool and program 
policies that do not permit take-homes for any patients are ill advised. Take-home medication often are 
an element critical for patient retention. SAMHSA recommends that medical directors of OTP’s should 
ensure that policies for the approval of take-home medication do not create barriers in patient retention 
(SAMHSA, 2015). 
Required testing for syphilis No SAMHSA guidelines do not reference syphilis or routine testing. U.S. Prevention services tasked force 
recommends syphilis testing for high risk populations, however, individuals in OTPs are not 
specifically designated as high-risk, at best, this should be individualized and not a cost incurred by all 
patients enrolled. Populations at increased risk based on incidence rates, include individuals who 
engage in high-risk sexual behavior, individuals who are HIV positive, and adults in correctional 
facilities (Bibbins-Domingo et al., 2016; Cantor, Pappas, Daeges, & Nelson, 2016). 
Required lockable container for take-homes 
(e.g., for unsupervised dosing) 
No While, SAMHSA guidelines do recommend OTPs ensure patients are aware of the need to secure 
medications as with any controlled substance but does not mandate a specific type of locking container. 
SAMHSA specifically states that having a specific container presents regulatory challenges such as a 
means to identify someone in treatment creating a potential to violate patient confidentiality as well as 
put the patient at risk for robbery or assault (SAMHSA, 2015). 
Administrative Requirements 
Required facility quality improvement plans Yes Facilities are required to maintain current quality assurance and control (SAMHSA, 2015). In addition 
SAMHSA, recommends continuous quality improvement plans should include: the program’s patient 
outcome goals; regular and continuous staff education; review and recertification of policies and 
procedures (SAMHSA, 2015). 
Mandatory use of patient central registry No Consistent with disaster preparedness, it has been noted that central registries can play an important role 
in continuity of care for OTP patients (Elliott, Benoit, Matusow, & Rosenblum, 2017). However, in the 
absence of empirical evidence, SAMHSA only recommends that patients be educated about the 





Required patient grievance policy Yes SAMHSA recommends that programs develop and display patient grievance policies to prevent, 
investigate, resolve patient complaints, and be responsive to patients’ feedback concerning their care 
(SAMHSA, 2015). 
Mandatory community relations 
liaison/committee 
Yes SAMHSA recommends that OTPs have policies and procedures to measure and minimize the negative 
impact an existing or new program may have on a community (SAMHSA, 2015). 
Mandatory policies on the use of students and/or 
interns 
No 
SAMHSA guidelines do not reference the use of students and/or interns (SAMHSA, 2015). 
Staffing Requirements 
Regulations on the employment of advanced 
practice professionals (e.g. nurse practitioners or 
physician assistants) 
Yes According to SAMHSA guidelines, medication-assisted treatment services may be provided by an 
authorized healthcare professional other than a physician such as an advanced practice nurse or 
physician assistant testing (SAMHSA, 2015). Many areas of the U.S have an insufficient number of 
physicians able or willing to treat substance use disorder with MAT (Sigmon, 2014). Use of advanced 
practice professionals may help remove barriers to treatment.  
Required minimum physician or medical 
director qualifications/certifications 
No Guidelines acknowledge that the medical director should have completed an accredited residency 
training program and have at least 1 year of experience in addiction medicine or addiction psychiatry. 
However, board certification in addiction psychiatry or addiction medicine is preferred, not required 
(SAMHSA, 2015). 
Required counselor to patient ratio’s No Federal guidelines state staff ratios should be sufficient to ensure that patients have reasonable and 
prompt access to counselors and receive counseling services at the required levels of frequency and 
intensity, however, there are no set patient-to-staff ratios specified in SAMHSA guidelines (SAMHSA, 
2015). 
Required employment of a clinical supervisor Yes Research has shown quality clinical supervision may potentially yield important benefits for counselor 
well-being (Knudsen, Roman, & Abraham, 2013). The primary goal of clinical supervision is to protect 
the welfare of the client, ensure the integrity of counseling services, and ensure quality counseling care 
(CSAT, 2009) 
Required employment of at least 1 CPR certified 
employee 
No SAMHSA guidelines do not reference the requirement of one CPR certified employee. OTPs are 
advised to operate with full understanding of requirements established by the state or health 
professional licensing boards (SAMHSA, 2015). 
Facility Operating Requirements  
Restrictions on the location of the facility No 
(with caveat) 
A significant number of OTP patients travel considerable distances to access treatment. Additionally, 
many statess have imposed unfavorable zoning restrictions making access difficult (Des Jarlais, Paone, 
Friedman, Peyser, & Newman, 1995; Peles, Schreiber, & Adelson, 2013; Rosenblum et al., 2011). 
Conflicts between OTP hours and patient work schedules as well as long, complicated public 
transportation routes (which can be limited or inaccessible during holidays) have been demonstrated as 
a barrier to access and retention (Reisinger et al., 2009). 
Caveat: D.C. requires OTPs be placed within access to public transit, which is evidence based 
(SAMHSA, 2015). 
Restrictions on the hours of operation Yes 
(with caveat) 
Historically, it was recommended that hours of operation to be scheduled in such a way to minimize 





acknowledged that odd hours are not always the most convenient for patients and were not typically 
conceived to address patient access or retention; but were perceived to promote further stigmatization.  
Participants in one study reported OTP clinical routines to be too restrictive and inconvenient, 
particularly with regard to the limited operating hours which were often in conflict with patients 
working schedules (Wu et al., 2012). Extended OTP operating hours may also help eliminate 
overcrowding (CSAT, 2005) SAMHSA recommends that OTPs provide services during hours that meet 
the needs of the majority of patients. Most importantly, OTPs should have hours which are outside of 
the traditional 8:00 a.m. to 5:00 p.m. schedule (SAMHSA, 2015). 
 
Caveat: State regulations on the hours of operations are highly variable by state, some are within the 
guidelines recommendations, and others are broad and may not ensure patients’ needs are met. 
Prohibition of patient loitering No A no-loitering policy is believed to help minimize medication diversion (CSAT, 2005).  However, 
research has pointed out that stigma and bias directed towards OTPs and their patients are the driving 
force for these types of regulations (Joseph et al., 2000). Thus, SAMHSA does not consider this as a 
best practice.  
Required to be open 7 days per week No Public transportation routes can be limited or inaccessible during holidays have been demonstrated as a 
barrier to access and retention (Rosenblum et al., 2011). 
 
A 2011 study examined commuting patterns among 23,141 methadone patients and more than half 
(60%) the patients traveled <10 miles and 6% travelled between 50 and 200 miles (Rosenblum et al., 
2011). With such a significant number of OTP patients traveling considerable distances to access 
treatment, this can become a barrier as a financial burden and physical burden with reduced public 
transport during these times.  
Required certificate of need for new facilities No SAMHSA guidelines do not reference the need for certificates of need (SAMHSA, 2015). 
Social Services Related  
Required patient discharge/aftercare plan Yes SAMHSA advises that aftercare planning should begin at admission and include the need for ongoing 
management of medical and mental health (SAMHSA, 2015). 
Mandatory inclusion and integration of patient’s 
family into treatment and goals 
Yes The involvement of family members contributes to positive treatment outcomes and provides benefits 
to the family members (SAMHSA, 2015). This should be completed only with informed consent of the 
patient and a signed release of information testing (SAMHSA, 2015). 
Required crisis stabilization services Yes It is recommended, staff should be trained and supported to deescalate physical or verbal threats in the 
event that dangerous or threatening situation cannot be deescalated (SAMHSA, 2015). 
Required parenting skills patient education Yes Individuals enrolled in an OTP who are parents, should be provided to education in parenting skills and 
child care (SAMHSA, 2015). 
Required life/social skills patient education No With the exception of family involvement, SAMHSA guidelines do not reference the requirement 
life/social skills education (SAMHSA, 2015). 





Requirements on facility cleanliness Yes SAMHSA recommends OTPs be clean and well maintained (SAMHSA, 2015). 
Restrictions on restrooms/Lavatory (e.g. # of 
restrooms) 
No It is recommended by SAMHSA that OTP’s consider the physical space, including restrooms, to meet 
the needs of female patients (SAMHSA, 2015). However, none of the identified state regulations 
pertained to the needs of female patients.  
Guidelines on facility ventilation/lighting No SAMHSA does not provide guidelines for facility ventilation and lighting (SAMHSA, 2015). 
Requirements on facility signage (e.g. no 
smoking signs or posted hours of operation) 
No  
(with caveat) 
The OTP’s responsibilities and patient rights including patient grievance policies should be posted at 
the treatment site, however, no other signs are listed (SAMHSA, 2015). 
 
SAMHSA also recommends facility offices and waiting areas should display the names and telephone 
number of individuals (e.g., physicians, hospitals, emergency medical technicians) who should be 
contacted in case of emergency or utilize 911 or similar local emergency resources (SAMHSA, 2015). 
 
Caveat: 5 of the 10 statess followed best practice guidance. Other states exceed SAMHSA guidelines 
and require signage that varied from the best practices. 







Table 3. Relationship between the average number of OTP Regulations, by category, and Select State Characteristics 
 Average # of Regulations1 
















State Size        
Small (N=15) 11.4 3.0 1.7 2.1 1.1 1.5 1.9 
Medium (N=25) 17.1 4.5 2.6 3.7 1.7 2.0 2.6 
Large (N=11) 15.4 5.2 2.6 4.0 1.4 0.6 1.5 
P-Value 0.272 0.265 0.317 0.154 0.409 0.131 0.524 
U.S. Census Regions        
Northeast (N=9) 18.8 5.6 3.1 4.1 1.7 1.9 2.4 
Midwest (N=12) 11.3 3.0 1.7 2.3 1.4 0.8 3.3 
South (N=17) 21.8 5.5 3.2 5.0 2.3 2.5 3.3 
West (N=13) 7.2 2.7 1.4 1.4 .3077 0.8 0.61 
P-Value <0.001 0.062 0.016 0.002 <0.001 0.025 0.062 
Political Leaning        
55% or greater voted Republican (N=18) 16.1 0.7 2.3 3.3 1.8 2.0 2.2 
55% or greater voted Democrat (N=21) 15.2 1.0 2.5 3.3 1.1 1.7 2.8 
Other (N=21) 14.1 0.9 2.4 3.2 1.4 1.1 1.9 
P-Value 0.849 0.056 0.955 0.986 0.317 0.296 0.718 
1Summated scales were calculated as the sum number of the individual regulations within each category of OTP regulations; as well as the overall number of regulations as 
reflected in the total column.  
Source: Laws for inclusion were identified using keyword searches on Westlaw, Justia, and state legislative websites. Data on the 2016 presidential election was obtained from 
























* Best practices were defined by Substance Abuse and Mental Health Services (SAMHSA) guidelines and supporting literature 
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